Safety and Efficacy of Paxlovid Against Omicron Variants of Coronavirus Disease 2019 in Elderly Patients

INTRODUCTION: Elderly patients are the most affected and vulnerable to COVID-19 and effective therapeutic interventions are urgently required. We clarified the safety and efficacy of Paxlovid in the treatment of elderly patients with coronavirus disease 2019 (COVID-19). METHODS: Patients aged over 6...

Descripción completa

Detalles Bibliográficos
Autores principales: Weng, Chengzhao, Xie, Rongcheng, Han, Guanjie, Yuan, Ya, Li, Shiqin, Wang, Chao, Wang, Xiaofeng, Jiang, Wei, Jiang, Libo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9875765/
https://www.ncbi.nlm.nih.gov/pubmed/36696068
http://dx.doi.org/10.1007/s40121-023-00760-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9875765/
https://www.ncbi.nlm.nih.gov/pubmed/36696068
http://dx.doi.org/10.1007/s40121-023-00760-x

Ejemplares similares